tradingkey.logo
tradingkey.logo
Search

Globus Medical Inc

GMED
Add to Watchlist
78.050USD
-4.860-5.86%
Close 10-30 16:00(ET)
10.48BMarket Cap
17.96P/E TTM
After-hours 19:00 (ET)78.050USD+0.035+0.04%

Globus Medical Inc (GMED) Stock Price Target & Forecast

Analyst Rating

Based on 17 analysts giving stock ratings to Globus Medical Inc in the past month.

Buy
2 Strong Buy
9 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
100.857USD+24.12%

GMED Analyst Recommendation Trends

In the current month, GMED has received 9 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the last month is 100.857.

2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
Strong Buy
2
2
2
2
2
2
2
2
Buy
9
9
9
8
8
9
9
9
Hold
6
6
6
5
5
5
5
5
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
17
17
17
15
15
16
16
16

GMED Analyst Rating for Peer Comparison

Updated: Oct 29, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Dexcom Inc
DXCM
13
12
4
0
0
29
Stryker Corp
SYK
11
13
5
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Abbott Laboratories
ABT
10
13
6
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
13
3
0
0
21

Financial Forecasting

Based on analysts' estimates, GMED EPS is projected to reach 1.197 in FY2026Q3, following reported EPS of 1.122 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.15
0.92
1.10
1.20
1.34
Actual
1.05
0.92
1.12
--
--
Surprise
-8.99%
-0.16%
+2.09%
--
--

FAQs

What is Globus Medical Inc's expected revenue for the next quarter?

Globus Medical Inc's expected revenue is 792.42M.

What is Globus Medical Inc's price target?

Analysts forecast that Globus Medical Inc's price target is USD 100.86, with the highest forecast at USD 125.00 and the lowest forecast at USD 84.00.

How have Globus Medical IncGMED's recent earnings per share performed?

The market expectation was USD 1.12, while Globus Medical IncGMED's earnings per share (EPS) for the previous quarter was USD 0.92. EPS for the next quarter is expected at USD 1.20.

What is the analyst rating for Globus Medical Inc?

Based on the ratings of Globus Medical Inc's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.